Latest drug resistance News

Ludwig Cancer Research Scientists to Present at AACR Annual Meeting
Strengthening surveillance and response for vector-borne diseases
Gut microbiome: meet Klebsiella pneumoniae – an opportunistic pathogen that is harmless to some, but causes severe disease in others
Liquid crystal nanoparticles supercharge antibiotics for cystic fibrosis
WHO World TB Day Message
WHO launches new guidance on the use of targeted next-generation sequencing tests for the diagnosis of drug-resistant TB and a new sequencing portal
AI can help predict whether a patient will respond to specific tuberculosis treatments, paving way for personalized care
Eliminating Malaria Requires New Solutions
New report documents increase in HIV drug resistance to dolutegravir
Studying Metastases And Drug Resistance In Lung Cancer
Synthetic polymers provide hope in the fight against invasive fungal infections
Drug-resistant TB responds rapidly to bedaquiline-based therapy
Parasite insights: the award-winning scientist teaching the world about deadly diseases
Bacteria can develop resistance to drugs they haven’t encountered before − scientists figured this out decades ago in a classic experiment
Prostate cancer treatment given new hope with MRFF win
Innovative modelling may help breast cancer patients who don’t respond to treatment
How a timekeeping gene affects tumor growth depends entirely on context
Structural study points way to better malaria drugs
Five Ludwig Cancer Research scientists named Fellows of the American Association for Cancer Research
Crop spray could lead to mass resistance in new-generation antifungal treatments
Grants will fund tuberculosis drug development
EnGeneIC’s breakthrough Armed Nanocell Drug Conjugate (ANDC) treatment shows promising results in Pancreatic cancer patients who have run out of treatment options
Drug resistance may make common infections like thrush untreatable
Preserving antimicrobials for the well-being of humans, animals, plants and ecosystems
November is Pancreatic Cancer Awareness Month
Leukaemia Foundation and HSANZ funding next generation of clinicians and researchers to save more Australian lives
WHO announces the members of the first Taskforce of AMR Survivors
HKUST-led Research Unveils Early Predictors of Glioma Evolution by CELLO2
Residue from household disinfectants may be leading to drug resistance in deadly bacteria
New target to beat cancer drug resistance
Ultrathin nanotech promises to help tackle antibiotic resistance
Botswana National HIV Reference Laboratory designated WHO Collaborating Centre of Excellence
WHO issues rapid communication on use of targeted next-generation sequencing for diagnosis of drug-resistant tuberculosis
Tumor metabolism atlas can help discover cancer mechanisms
Nanorobots successfully deal with oral fungal infections “rapidly and precisely”
Healing wounds with differential equations
Ludwig Lausanne’s Douglas Hanahan elected Foreign Member of the Royal Society
Maths unlocks molecular interactions that open window to how life evolved
WHO urges increased implementation of recommended tools to combat malaria
WHO releases first-ever Standard on universal access to rapid TB diagnostics
Ludwig Cancer Research scientists to present at AACR Annual Meeting
Resistance-fighting antimalarial drug candidate enters the clinic
Significant step in fight against drug resistance in TB
WHO welcomes signing of sublicences with three manufacturers to produce long-acting injectable cabotegravir for HIV prevention
Two researchers honoured in NHMRC Research Excellence Awards
New way to study molecular drivers of cancer
Simplified HIV treatment options just as effective: major clinical trial
Research Reveals Why Cancers Stop Responding to Kinase-Blocking Drugs and Come Back Stronger